MARKET

GELS

GELS

Gelteq Limited
NASDAQ
0.7390
+0.0090
+1.23%
Closed 15:56 03/30 EDT
OPEN
0.7030
PREV CLOSE
0.7300
HIGH
0.7400
LOW
0.7013
VOLUME
12.60K
TURNOVER
--
52 WEEK HIGH
4.110
52 WEEK LOW
0.6401
MARKET CAP
7.92M
P/E (TTM)
-1.5971
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GELS last week (0323-0327)?
Weekly Report · 20h ago
Gelteq Warned by Nasdaq Over Minimum Bid Price Compliance
TipRanks · 6d ago
Gelteq gets Nasdaq notice after shares trade below $1 for 30 days
Reuters · 6d ago
Weekly Report: what happened at GELS last week (0316-0320)?
Weekly Report · 03/23 10:13
Gelteq Ltd. files initial beneficial ownership statement for Chief Scientific Officer Paul Michael Wynne
Reuters · 03/19 00:17
Gelteq Ltd. director Simon Szewach files initial beneficial ownership statement
Reuters · 03/19 00:16
Gelteq Ltd. Head of Sales and Marketing Bradley Glenn Karp files initial beneficial ownership statement
Reuters · 03/18 23:19
Gelteq Ltd. CEO Nathan J. Givoni files initial beneficial ownership statement
Reuters · 03/18 23:18
More
About GELS
Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.

Webull offers Gelteq Ltd stock information, including NASDAQ: GELS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GELS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GELS stock methods without spending real money on the virtual paper trading platform.